Skip to Main Content

++

INTRODUCTION

++

Nearly 10% of the population older than 65 years has atherosclerotic lower extremity peripheral arterial disease. Older patients and those with risk factors may have up to a 25% incidence of lower extremity peripheral arterial disease.1 Percutaneous vascular interventions are rapidly emerging as a less invasive therapy for symptomatic lower extremity occlusive arterial disease.2,3,4 Despite recent advances, restenosis remains a significant problem with catheter-based revascularization. By delivering high local doses, drug-eluting stents have the potential to overcome the limitations of restenosis and advance stent-based therapies for lower extremity peripheral arterial disease (Table 39-1).

++
Table Graphic Jump Location
TABLE 39-1.

Challenges of Stent-Based Drug Delivery

++

There is interest in the applicability of drug eluting stent (DES) in other arterial beds as well. Most studies and case series have focused on the efficacy in the renal arteries, intracranial circulation, and extracranial carotid or vertebral arteries. To date, the bulk of clinical studies have been in the evaluation of drug-eluting stents to reduce restenosis in the coronary arteries, with dramatic results, which are simultaneously changing the treatment paradigm for multivessel coronary artery disease and raising long-term safety concerns.

++

MECHANISM OF BALLOON ANGIOPLASTY AND STENTING

++

Balloon angioplasty of occlusive arterial disease results in a lumen diameter gain through several mechanisms. Angioplasty compresses the atherosclerotic plaque, shifting it laterally and axially, as well as causing a "controlled" intimal and medial dissection.5 Angioplasty is, however, limited by the acute elastic recoil properties of the arterial wall with up to a 40% loss in lumen area.5,6 Flow-limiting dissections can occur and may lead to acute or subacute vessel closure.7 As a scaffold, stents improve the initial results of percutaneous interventions by increasing the arterial lumen and tacking up intimal flaps between the stent and the vessel wall. The scaffolding properties of stents virtually eliminate acute arterial recoil and reduce the subsequent risk of acute or subacute vessel closure.5,7,8,9

++

RESTENOSIS PATHOPHYSIOLOGY

++

Restenosis is characterized by three processes: acute vessel recoil, late vessel remodeling (negative/constrictive remodeling), and neointimal hyperplasia.5,7,10 Stents effectively eliminate acute vessel recoil and negative vessel remodeling. In-stent restenosis is, therefore, almost entirely owing to neointimal hyperplasia.8,11,12 Compared to balloon angioplasty, stents can cause more tissue proliferation by virtue of greater chronic injury to the vessel wall. The long-term effectiveness of stents is mitigated by this "late loss" of the arterial lumen because of tissue proliferation within the stent.

++

The pathophysiology of vascular repair mechanisms after angioplasty and stenting has been extensively studied in a variety of experimental models. Angioplasty and stenting ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessCardiology Full Site: One-Year Subscription

Connect to the full suite of AccessCardiology content and resources including textbooks such as Hurst's the Heart and Cardiology Clinical Questions, a unique library of multimedia, including heart imaging, an integrated drug database, and more.

$595 USD
Buy Now

Pay Per View: Timed Access to all of AccessCardiology

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.